Simplex Trading
TTPH

Simplex Trading’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Simplex Trading’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-4
Closed -$8K – 8236
2018
Q4 		$8K Sell
4
-73
-95% -$2.85K ﹤0.01% 6021
2018
Q3 		$423K Buy
+77
New +$4.92K ﹤0.01% 2809
2018
Q2 		– Sell
-17
Closed -$70K – 8156
2018
Q1 		$70K Sell
17
-12
-41% -$1.05K ﹤0.01% 2105
2017
Q4 		$52K Buy
29
+8
+38% +$1.02K ﹤0.01% 2421
2017
Q3 		$54K Buy
21
+11
+110% +$1.47K ﹤0.01% 2237
2017
Q2 		$39K Buy
+10
New +$1.54K ﹤0.01% 2632
2017
Q1 		– Sell
-6
Closed -$12K – 7096
2016
Q4 		$12K Buy
+6
New +$475 ﹤0.01% 3598
2016
Q3 		– Sell
-5
Closed -$48K – 6781
2016
Q2 		$48K Sell
5
-2
-29% -$183 ﹤0.01% 2109
2016
Q1 		$60K Buy
7
+4
+133% +$400 ﹤0.01% 1801
2015
Q4 		$20K Sell
3
-23
-88% -$4.59K ﹤0.01% 2711
2015
Q3 		$482K Buy
26
+15
+136% +$11K 0.04% 462
2015
Q2 		$23K Buy
11
+9
+450% +$7.36K ﹤0.01% 2351
2015
Q1 		$15K Buy
+2
New +$1.5K ﹤0.01% 2581
2014
Q4 		– Hold
0
– – – 3881

Other funds holding TTPH

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Simplex Trading's TTPH Position: Q1 2019 in Review

Simplex Trading sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q1 2019, closing a stake of 671 shares — an estimated $17.1K sold.

Simplex Trading first reported a position in TTPH in Q4 2014 and held it in 11 quarters. The position peaked at $620K in Q3 2015. 78 funds tracked by Wall St. Rank hold TTPH as of Q1 2019.

  • Simplex Trading reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q1 2019 after selling out during the quarter.
  • Simplex Trading sold 671 Tetraphase Pharmaceuticals, Inc. shares in Q1 2019, an estimated $17.1K.
  • Simplex Trading first reported a position in Tetraphase Pharmaceuticals, Inc. in Q4 2014 and held it in 11 quarters.
  • Simplex Trading's Tetraphase Pharmaceuticals, Inc. position peaked at $620K in Q3 2015.
  • 78 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q1 2019.

Based on Simplex Trading's 13F filing for Q1 2019, filed 18 Apr 2019.